Drug Giant AstraZeneca Launches Evinova to Quicken Clinical Trials

Evinova aims to use AI to design studies, automate cost calculations, and determine feasibility for drug testing.

Pharmaceutical giant AstraZeneca announced on Monday the spin-off and launch of a new digital health company called Evinova. AstraZeneca says the new company will operate independently within the AstraZeneca ecosystem.